文献速递神经肿瘤功能神经外科

伽玛刀放射外科治疗三叉神经鞘瘤:20年经验及长期治疗结局

Gamma knife radiosurgery for trigeminal schwannoma: a 20-year experience with long-term treatment outcome.
PubMed 文献 · J Neurooncol · 2018-06-21

回顾性分析1994年1月至2013年1月间接受伽玛刀放射外科治疗的32例三叉神经鞘瘤患者,中位随访90.5个月,3年、5年和10年肿瘤控制率分别为93.8%、86.2%和80.8%。多因素分析显示靶体积是唯一显著影响肿瘤控制的因素,大于5 cm3的肿瘤更易进展(p=0.011)。作者认为伽玛刀是安全有效的治疗方式,尤其对小肿瘤,需延长随访观察临床反应。

要点

  • 32例三叉神经鞘瘤患者接受伽玛刀治疗,中位随访90.5个月,10年肿瘤控制率为80.8%。
  • 靶体积是唯一显著影响肿瘤控制的因素,大于5 cm3的肿瘤更易进展(p=0.011)。
  • 囊性肿瘤较实性肿瘤更易出现暂时性增大和症状改变,5例(15.6%)症状结局不佳。

核心结论

  • 伽玛刀放射外科可作为三叉神经鞘瘤安全有效的治疗方式,尤其适用于小肿瘤,但需延长随访观察以判定临床反应。

研究设计与样本

  • 回顾性研究纳入1994年1月至2013年1月间接受伽玛刀放射外科治疗且随访至少2年的32例三叉神经鞘瘤患者,回顾病历和手术记录以评估影响肿瘤控制率和症状结局的因素。
  • 患者中位年龄57.5岁(最大81岁,四分位距51-67岁),中位肿瘤体积3.55 cm3(最大25.2 cm3,四分位距2.0-6.2 cm3)。
  • 中位边缘剂量13.0 Gy(最大18.0 Gy,四分位距12.5-15 Gy),中位最大剂量23.8 Gy(最大35 Gy,四分位距21.7-25.0 Gy)。

主要发现

  • 中位随访90.5个月(最大281个月,四分位距49-139.75个月),3年、5年和10年 actuarial 肿瘤控制率分别为93.8%、86.2%和80.8%。
  • 多因素分析显示靶体积是唯一显著决定肿瘤控制率的因素,大于5 cm3的肿瘤更易进展(p=0.011)。
  • 囊性肿瘤较实性肿瘤有更高的暂时性增大和暂时症状改变发生率。
  • 5例患者(15.6%)出现症状结局不佳。
  • 2例患者(6.25%)出现并发症,分别为脑积水和放射性三叉神经病变。

临床怎么用

  • 作者认为伽玛刀放射外科可作为三叉神经鞘瘤安全有效的治疗方式,尤其适用于小肿瘤。
  • 作者指出需要延长随访观察时间以判定伽玛刀放射外科的临床反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study evaluated the long-term tumor control rate (TCR) and symptomatic outcomes of patients treated with gamma knife radiosurgery (GKRS) for trigeminal schwannomas (TSs). METHODS: Thirty-two patients with TS who underwent GKRS between January 1994 and January 2013 with at least 2 years of follow-up were enrolled in the study. Clinical charts and surgical records were retrospectively reviewed to evaluate factors affecting TCR and symptomatic outcomes. The median patient age was 57.5 years (max = 81, interquartile range [IQR] = 51-67), and the median tumor volume was 3.55 cm3 (max = 25.2 cm3, IQR = 2.0-6.2 cm3). The median marginal and maximum doses were 13.0 Gy (max = 18.0 Gy, IQR = 12.5-15 Gy) and 23.8 Gy (max = 35 Gy, IQR = 21.7-25.0 Gy), respectively. RESULTS: At a median follow-up of 90.5 months (max = 281 months, IQR = 49-139.75 months), the actuarial 3-, 5-, and 10-year TCR were 93.8, 86.2, and 80.8%, respectively. Our data and multivariate analysis indicated that the target volume was the only significant factor determining TCR and that larger tumors (> 5 cm3) were more likely to progress (p = 0.011). Cystic tumors had a higher incidence of transient enlargement and temporary symptom change compared to those in solid tumors. An unfavorable outcome of symptoms was observed in five patients (15.6%). Complications were observed in two patients (6.25%), including hydrocephalus and radio-induced trigeminal neuropathy, respectively. CONCLUSIONS: GKRS can be a safe and effective treatment modality for TS with long-term follow-up, especially for small tumors. An extended period of follow-up observation is required to conclude the clinical response to GKRS.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Ryu J, Lee SH, Choi SK, et al. Gamma knife radiosurgery for trigeminal schwannoma: a 20-year experience with long-term treatment outcome. J Neurooncol. 2018. PMID: 29931615. doi:10.1007/s11060-018-2934-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。